RxDoctor Payments Data

Zoya Ahmad

Physician Assistant · Phoenix, AZNPI 1811452782

Payments from drug & device makers

$8,577in general payments, 2019–2025

Across 176 payments — averaging $48.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Medtronic$3K
  • Atricure, Inc.$2K
  • Sanofi-aventis U.S. LLC$186
  • Itamar Medical Inc$147
  • Cvrx, Inc.$146
  • plus $631 from 9 others

What the payments were for

  • Travel & lodging$2,60430%
  • Food & beverage$5,97270%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,577 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$89,263
Medicare patients
593
Services billed
1,396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban202$228,703
XareltoRivaroxaban96$108,720
MultaqDronedarone Hcl25$26,930
Dofetilide59$8,709
Metoprolol Succinate308$5,242
Flecainide Acetate87$4,911
SotalolSotalol Hcl135$3,434
Amiodarone Hcl62$1,235
Diltiazem 24hr Er (Cd)Diltiazem Hcl34$1,177
Diltiazem 24hr ErDiltiazem Hcl28$1,124
Metoprolol Tartrate33$210
Warfarin Sodium26$190
Carvedilol11$101

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$88$228,703202 claims
Johnson & JohnsonXarelto$61$108,72096 claims
Sanofi-aventis U.S. LLCMultaq$186$26,93025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →